Annual Report 2022

 

Protein design reached two major milestones this year: Our Institute succeeded in producing its first fully-approved medicine, and our spinout companies have together raised over one billion dollars in capital. 

We are pleased to present this overview of the progress made at the Institute for Protein Design during the past year.

2022 Annual Report